XHKG
0954
Market cap19mUSD
Jul 02, Last price
0.29HKD
Name
Changmao Biochemical Engineering Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Changmao Biochemical Engineering Company Limited, along with its affiliates, focuses on the production and global sale of organic acids. These products serve diverse industries, including food additive manufacturing, chemical production, and pharmaceuticals, reaching markets across Mainland China, Europe, the Asia Pacific region, the United States, and other international territories. Their extensive product line features fumaric acid, maleic acid, various forms of malic acid (L-, D-, and DL-), L(+)-, D(-)-, and DL-tartaric acids, L-aspartic acid, and aspartame. These compounds are utilized as essential food additives, pharmaceutical excipients, and active pharmaceutical ingredients, among other uses. Furthermore, the company is actively engaged in the research and development of medicinal and nutraceutical products, the manufacturing and distribution of additional food additives, the trade of organic acids, and property investment. Founded in 1992, Changmao Biochemical Engineering Company Limited is headquartered in Changzhou, People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||